APA引文

Lim, K. Y., Huynh, T. N. A., Wei, G., Kuriakose, J., Fazli, O., Pook, D., . . . Ranasinghe, W. (2025, April). Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer. BJUI Compass.

Chicago Style (17th ed.) Citation

Lim, Kylie Yen‐Yi, et al. "Intravesical Gemcitabine and Docetaxel Vs. Re‐induction Bacillus Calmette Guerin as First‐line Salvage Therapy for Non‐muscle Invasive Bladder Cancer." BJUI Compass Apr. 2025.

MLA引文

Lim, Kylie Yen‐Yi, et al. "Intravesical Gemcitabine and Docetaxel Vs. Re‐induction Bacillus Calmette Guerin as First‐line Salvage Therapy for Non‐muscle Invasive Bladder Cancer." BJUI Compass, Apr. 2025.